G42 Healthcare
The programme, which is focused on providing preventive and personalised healthcare for citizens of the United Arab Emirates, wants more citizens to offer samples.
G42 Healthcare has partnered with Seegene to offer its new Seegene Mobile Station to various territories across the Middle East and North Africa. Each station can conduct up to 2,000 tests per day.
The Abu Dhabi-based company is reportedly in talks to co-develop a COVID-19 test that can detect positive cases of the coronavirus from exhaled nasal air.
The Abu Dhabi technology company is currently spearheading the world’s first Phase III trials of one vaccine, with volunteers from the UAE and Bahrain taking part.